Skip to content
Contact Us
Webinar - On Demand

Effective Practices for Integrating Biomarkers, Biospecimens, and Science - from Concept, through Clinic, to Cloud

Date: July 1, 2023

Duration: 43 Minutes

In the rapidly evolving world of precision medicine, the successful integration of high-quality biospecimens and well-defined biomarkers is a fundamental aspect. Together with robust scientific methodologies and validation procedures, they drive discovery, clinical development, and the advent of Artificial Intelligence (AI)-driven diagnostics.
 
This webinar delves into the practical application of biospecimens in critical areas like neurodegeneration, immuno-oncology, and oncology. It outlines the development of assays for clinical application, the creation of multiplexed Immunohistochemistry (IHC) assays, and the use of sequenced biospecimens in the development and diagnosis of targeted therapies.
 
Key topics will also highlight the value of Tissue Microarrays (TMAs), the advantage of accessing diverse disease indications, the necessity for substantial tissue cohorts for clinical trial assay validation, and the role of tissue images (Hematoxylin & Eosin (H&E), IHC) and related sample data (Next-Generation Sequencing (NGS)) in shaping AI-based diagnostics.



Topics covered:

  • Gain insights into best practices for successful biomarker discovery and clinical application.
     
  • Understand the pivotal role of high-quality biological specimens in therapeutic development.
     
  • Delve into case studies that demonstrate the successful realization of these strategies across a variety of therapeutic areas.
     
  • Comprehend the current trends and future potential of AI-driven diagnostics in the field of precision medicine.

Register to Watch Webinar On Demand
Speakers

Robert Snyder

Robert Snyder PhD
Precision for Medicine

A seasoned expert with a 20-year track record in genomics, specializing in in vitro diagnostic assay development and bioinformatics. Committed to advancing medical science, he is proficient in regulatory V&V study designs and understands the nuances of orthogonal methods. A collaborative partner in biomedical development, Dr. Snyder champions the critical transition of biospecimens from benchtop to bedside.

Amanda-Woodroofe_Square_260px

Amanda Woodrooffe PhD
Precision for Medicine

Experienced leader of scientific operations for drug discovery in both the pharmaceutical and CRO industries. Driven to provide actionable data enabling biopharmaceutical research and development. Collaborative partner ensuring licensing and scientific support for corporate development initiatives.